Filling the need for trusted information on national health issues…

Intellectual Property and Trade

  • Your Selections:

Refine Results

date

Tags

TPP Would Create ‘Damaging Monopolies,’ Hurt Health System

Washington Post: Letter to the Editor: The Trans-Pacific Partnership would worsen health crises Rohit Malpani, director of policy and analysis for Médecins Sans Frontières’s Access Campaign “The April 25 editorial ‘A healthy agreement’ suggested the [Trans-Pacific Partnership (TPP)] won’t significantly restrict access to medicines, including in developing countries. [However, some]…

Public Health Threat From TPP Agreement ‘May Be Overblown’

Washington Post: A healthy agreement Editorial Board “…No argument against the proposed [Trans-Pacific Partnership (TPP)] trade agreement packs more emotional punch than the claim that the deal would be bad for people’s health — and even result in avoidable deaths — both in the United States and in the 11…

CGD Blog Post Discusses Research On Impact Of Patents On Drug Availability

Center for Global Development’s “Global Health Policy Blog”: What Drug Patents Do Is Complicated: A Belated Contribution from Jenny Lanjouw Helps Sort It Out Kimberly Ann Elliott, senior fellow at CGD, discusses research by former CGD fellow Jenny Lanjouw and her coauthors, Iain Cockburn and Mark Schankerman, on patents and…

GlaxoSmithKline Taking Steps To Help Reduce Drug Prices In Lower-Income Countries

The Guardian: GlaxoSmithKline to lower drug prices in poorer countries “GlaxoSmithKline is taking action to make medicines more affordable in developing countries, including waiving patent protection for new drugs in the world’s poorest nations. … The measures will affect 85 countries, helping more than two billion people, and benefit Africa…

U.S. Trade Deals Have Not Increased Drug Prices In Other Countries

Foreign Affairs: Why U.S. Trade Deals Haven’t Exported U.S. Drug Prices Thomas J. Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations (CFR), and adjunct professor of law at Georgetown University “Pharmaceuticals are at the center of the debate over the Trans-Pacific Partnership (TPP),…

Public-Private Partnerships Create Opportunity To Engage China In Global Health Security

Forbes: China’s Contribution To Global Health Security Through Pharma Partnerships Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations and professor at Seton Hall University’s School of Diplomacy and International Relations “…[A] public-private partnership (PPP) can offer an integrated and systematic approach to the development and…

TPP Provisions Could Threaten Access To Affordable Medicines

PLOS Medicine: Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the U.S. and Elsewhere Brook K. Baker, professor at Northeastern University School of Law, discusses the Trans-Pacific Partnership’s (TPP) potential impact on access to affordable medicines if its provisions are ratified, writing, “[Intellectual…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.